Company profile for Integral Molecular

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Integral Molecular, our greatest strength is our diverse scientific team. Our scientists have extensive expertise in membrane proteins, antibodies, structural biology, and virology, which we apply to provide exceptional solutions and tackle challenging therapeutic targets. Integral Molecular is a research-driven biotechnology company. We offer a broad array of innovative technologies and a pipeline of therapeutic antibodies...
At Integral Molecular, our greatest strength is our diverse scientific team. Our scientists have extensive expertise in membrane proteins, antibodies, structural biology, and virology, which we apply to provide exceptional solutions and tackle challenging therapeutic targets. Integral Molecular is a research-driven biotechnology company. We offer a broad array of innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes. Integral Molecular’s leadership team has been working together for 20 years.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3711 Market St, Philadelphia, Pennsylvania
Telephone
Telephone
(215) 966-6061
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/integral-molecular-out-licenses-first-in-class-antibody-panel-targeting-slc2a4-glucose-transporter-302483111.html

PR NEWSWIRE
17 Jun 2025

https://www.prnewswire.com/news-releases/integral-moleculars-out-licensed-bispecific-antibody-enters-clinical-trial-for-treating-solid-tumors-302393696.html

PR NEWSWIRE
06 Mar 2025

https://www.prnewswire.com/news-releases/integral-molecular-reveals-mechanism-underlying-exquisite-specificity-of-claudin-6-therapeutic-antibody-being-developed-for-solid-tumors-301714722.html

PR NEWSWIRE
05 Jan 2023

https://www.prnewswire.com/news-releases/integral-molecular-launches-new-product-lines-of-safe-reporter-viruses-for-vaccine-development-and-pandemic-preparedness-301655280.html

PRNEWSWIRE
20 Oct 2022

https://www.prnewswire.com/news-releases/integral-molecular-and-optimeos-life-sciences-enter-partnership-to-develop-mrna-and-dna-based-gene-therapies-using-molecular-targeting-301564088.html

PRNEWSWIRE
08 Jun 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-04-26/lonza-and-integral-molecular-announce-new-collaborative-strategy/

CONTRACTPHARMA
26 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty